featured
EASD 2021: Continuous Glucose Monitoring Data Confirm Benefits of Tirzepatide Over Degludec in Type 2 Diabetes
Time in tight euglycemic range was increased, particularly with the higher doses of tirzepatide
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.